The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

Diabetes Care

Volumn 37, Issue 12, 2014, Pages 3244-3252

  Hugenschmidt, Christina E ^a   Lovato, James F ^a   Ambrosius, Walter T ^a   Bryan, R Nick ^b   Gerstein, Hertzel C ^c   Horowitz, Karen R ^d   Launer, Lenore J ^e   Lazar, Ronald M ^f   Murray, Anne M ^g   Chew, Emily Y ^h   Danis, Ronald P ⁱ   Williamson, Jeff D ^a   Miller, Michael E ^a   Ding, Jingzhong ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HAMILTON HEALTH SCIENCES   (Canada)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f Columbia University College of Physicians and Surgeons ^*  (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h NATIONAL EYE INSTITUTE   (United States)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DIGIT SYMBOL SUBSTITUTION TEST; DISEASE SEVERITY; FEMALE; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; BRAIN; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COGNITION DISORDERS; COMPLICATION; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; BRAIN; CARDIOVASCULAR DISEASES; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RISK FACTORS;

EID: 84911874575     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0502     Document Type: Article

References (40)

1. Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011;37:56-74
2. Cheung N, Mosley T, Islam A, et al. Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain 2010;133(Pt 7):1987-1993
3. Longstreth W Jr, Larsen EK, Klein R, et al. Associations between fi ndings on cranial magnetic resonance imaging and retinal photography in the elderly: the Cardiovascular Health Study. Am J Epidemiol 2007;165:78-84
4. Manschot SM, Biessels GJ, de Valk H, et al.; Utrecht Diabetic Encephalopathy Study Group. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007;50:2388-2397
5. Manschot SM, Brands AM, van der Grond J, et al.; Utrecht Diabetic Encephalopathy Study Group. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006;55:1106-1113
6. Wong TY, Klein R, Sharrett AR, et al.; ARIC Investigators. Atheroslerosis Risk in Communities Study. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74
7. Saczynski JS, Siggurdsson S, Jonsson PV, et al. Glycemic status and brain injury in older individuals: the Age Gene/Environment Susceptibility-Reykjavik Study. Diabetes Care 2009;32: 1608-1613
8. Schmidt R, Launer LJ, Nilsson LG, et al.; CASCADE Consortium. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004;53:687-692
9. Bryan RN, Bilello M, Davatzikos C, et al. Effect of diabetes on brain structure: the Action to Control Cardiovascular Risk in Diabetes MR imaging baseline data. Radiology 2014;272:210-216
10. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 2005;206:319-348
11. Gerstein HC, Ambrosius WT, Danis R, et al.; ACCORD Study Group. Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care 2013;36:1266-1271
12. Mimoun L, Massin P, Steg G. Retinal microvascularisation abnormalities and cardiovascular risk. Arch Cardiovasc Dis 2009;102:449-456
13. Kwa VI, van der Sande JJ, Stam J, Tijmes N, Vrooland JL; Amsterdam Vascular Medicine Group. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology 2002;59:1536-1540
14. Qiu C, Cotch MF, Sigurdsson S, et al. Microvascular lesions in the brain and retina: The Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol 2009;65:569-576
15. Last D, Alsop DC, Abduljalil AM, et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007;30:1193-1199
16. Wong TY, Mosley TH Jr, Klein R, et al.; Atherosclerosis Risk in Communities Study. Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 2003;61:806-811
17. Baker ML, Marino Larsen EK, Kuller LH, et al. Retinal microvascular signs, cognitive function, and dementia in older persons: the Cardiovascular Health Study. Stroke 2007;38:2041-2047
18. Wong TY, Klein R, Sharrett AR, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 2002;33:1487-1492
19. Akisaki T, Sakurai T, Takata T, et al. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese Elderly Diabetes Intervention Trial (J-EDIT). Diabetes Metab Res Rev 2006;22:376-384
20. van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein HC. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 2007;36:164-170
21. ACCORD Study Group; Buse JB, Bigger JT, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 2007;99(12A):21i-33i
22. Chew EY, Ambrosius WT, Howard LT, et al.; ACCORD Study Group. Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). Am J Cardiol 2007;99(12A):103i-111i
23. Launer LJ, Miller ME, Williamson JD, et al.; ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011;10:969-977
24. Atkinson HH, Rosano C, Simonsick EM, et al.; Health ABC study. Cognitive function, gait speed decline, and comorbidities: the Health, Aging and Body Composition study. J Gerontol A Biol SciMed Sci 2007;62:844-850
25. Chew EY, Ambrosius WT. Update of the ACCORD Eye Study. N Engl J Med 2011;364:188-189
26. Folstein MF, Folstein SE, McHugh PR. "Minimental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
27. Salthouse TA, Skovronek E. Within-context assessment of age differences in working memory. J Gerontol 1992;47:110-120
28. Kopelman MD. The Autobiographical Memory Interview (AMI) in organic and psychogenic amnesia. Memory 1994;2:211-235
29. MacLeod CM. Half a century of research on the Stroop effect: an integrative review. Psychol Bull 1991;109:163-203
30. Goldszal AF, Davatzikos C, Pham DL, Yan MX, Bryan RN, Resnick SM. An image-processing system for qualitative and quantitative volumetric analysis of brain images. J Comput Assist Tomogr 1998;22:827-837
31. Lao Z, Shen D, Liu D, et al. Computer-assisted segmentation of white matter lesions in 3D MR images using support vectormachine. Acad Radiol 2008;15:300-313
32. Ding J, Strachan MW, Reynolds RM, et al.; Edinburgh Type 2 Diabetes Study Investigators. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010;59:2883-2889
33. Lesage SR, Mosley TH, Wong TY, et al. Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology 2009;73:862-868
34. Jacobson AM, Ryan CM, Cleary PA, et al.; Diabetes Control and Complications Trial/EDIC Research Group. Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia 2011;54:245-255
35. Haan M, Espeland MA, Klein BE, et al.; Women 's Health Initiative Memory Study and the Women's Health Initiative Sight Exam. Cognitive function and retinal and ischemic brain changes: the Women 's Health Initiative. Neurology 2012;78:942-949
36. Qiu C, Sigurdsson S, Zhang Q, et al. Diabetes, markers of brain pathology and cognitive cognition: the Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol 2013;75:138-146
37. Kawasaki R, Cheung N, Mosley T, et al. Retinal microvascular signs and 10-year risk of cerebral atrophy: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010;41:1826-1828
38. Mosley TH Jr, Knopman DS, Catellier DJ, et al. Cerebral MRI fi ndings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology 2005;64:2056-2062
39. Crosby-Nwaobi RR, Sivaprasad S, Amiel S, Forbes A. The relationship between diabetic retinopathy and cognitive impairment. Diabetes Care 2013;36:3177-3186
40. Reijmer YD, van den Berg E, de Bresser J, et al.; Utrecht Diabetic Encephalopathy Study Group. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Diabetes Metab Res Rev 2011;27: 195-202